WHO’s New Pricing Policy Guideline Makes Medicines More Affordable
Sydney Otomancek2020-10-12T16:04:04-04:00October 12th, 2020|Categories: Featured, Industry News|Tags: Drug costs, Equal access, HEOR, pharma. healthcare, pricing, WHO|
A new WHO guideline aims to help governments overcome the barrier of high prices for pharma products, enabling them to [...]
CVS Health’s Value Constrained by Politics
Sydney Otomancek2020-09-23T14:07:35-04:00September 23rd, 2020|Categories: Featured, Industry News|Tags: CVS, HEOR, pharma. healthcare, value|
Market analysts believe that CVS Health’s (NYSE:CVS) stock price is poised to do well in the event of a Biden [...]
Receive essential insights, resources and content direct to your inbox!
Hit subscribe to stay informed!
Advertisement
Latest News
Featured Webinars
Practical AI: Adding Insight to the Patient Journey with Digital Phenotyping
Thursday, May 23, 2024
Sponsor: OM1
Insights from the 2024 Salary Survey Report by HealthEconomics.com
Wednesday, May 1, 2024
Webinar Host: Scientist.com
Beyond Accelerated Approvals: External Control Arms
Wednesday, April 10, 2024
Sponsor: Cardinal Health
Categories
Artificial Intelligence
Careers
Clinical Trials
Cost Effectiveness
Data Analytics & Syndicated Reports
Healthcare Financing
Health Databases
Health Equity
Health Policy
Health Tech Assessment
HEOR
Integrated Evidence Assessment & Planning
Market Access
Medical Affairs
Patient Outcomes & Engagement
Press Release
Pricing & Reimbursement
Real World Data
Real World Evidence
Value Assessment
Value Communication